UiPath Inc. (NYSE:PATH) is one of the worst AI stocks to invest in according to Reddit. On February 6, UiPath announced the acquisition of WorkFusion, which is a pioneer in AI agents specialized in ...

CORRECTION: An earlier version of this story said Health Canada had approved several generics for semaglutide. They have received several submissions for approval for ...

In recent days, UiPath has drawn fresh attention as easing geopolitical tensions and a friendlier backdrop for technology spending have supported renewed interest in AI automation platforms, including ...

UiPath is at an inflection point, with stabilizing SaaS metrics, renewed growth, and a strong AI-driven product roadmap. PATH’s Maestro platform uniquely integrates deterministic RPA and probabilistic ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Why Psychologists Haven’t Agreed on the Basic Human Values—Until Now Personality traits are stable patterns in the way we think, feel, and behave (Johnson, 1997, p. 74). In a previous PT post, I ...

There may be no enterprise job today that can’t be enhanced through the use of automation and AI, and agentic AI represents the next step toward fully realizing that potential. So says Daniel Dines, ...

UiPath (PATH +3.32%) isn't just an automation company anymore. It's quietly transforming into a key infrastructure player at the intersection of automation, data, and artificial intelligence (AI). To ...

For businesses struggling to get their artificial intelligence projects into production, automation and orchestration could be the unifying forces that get them a return on their investment. UiPath ...

UiPath stock surged more than 40% this week following a new collaboration with ChatGPT maker OpenAI on agentic AI technology. The rally actually started last week when UiPath announced integrations ...

If you use Excel 40 hours a week (and those are the weeks you are on vacation), welcome to the MrExcel channel. Home to 2,400 free Excel tutorials. Bill "MrExcel" Jelen is the author of 67 books about ...

Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...